Ebook

HPAPI Development and Manufacturing Trends

The current trend of increased potency of drug substances is driving the need for better cleaning methods to reduce cross contamination.

05.20.21

HPAPI Market Trends
Rising demand for targeted cancer and other treatments driving HPAPI growth
Read More >>

HPAPI Technology Trends
Expanding HPAPI sector driving innovation in containment technology.
Read More >>

High Potency APIs: Some Bad News, Some Good News
The growing use of HPAPIs has created some challenges in the lab, while at the same time offering advantages as well.
Read More >>

Antibody-Drug Conjugates: Catalysts for Chemistry
(ADCs), also known as armed antibodies, are highly anticipated to be the source of next generation frontline oncolytic therapy.
Read More >>

Suggested For You

New CDMO Vector BioMed Launches Operations

Lilly to Invest $450M at Manufacturing Site in Research Triangle Park

Vio Chemicals

Lonza Further Invests in Drug Product Manufacturing Capabilities

Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany

First Patient is Dosed with Triumvira's Investigational TAC-T Cell Adoptive Immunotherapy

November 2021: Auction Featuring Oral Thin Film and Capsule Technology – Production & Packaging

Strategies to Successfully Transfer & Scale Rx & OTC Drugs

Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer

November 2021: Auction of Pharmaceutical Equipment from Intec Pharma Ltd.

Everest Medicines, Sinovent, SinoMab Enter Global BTK Inhibitor Mfg. Pact

Tevogen Completes Tech Transfer to CDMO BioCentriq

BioVaxys Reports Progress on Covid-19 Vax Candidate

Vaccine Developer Intravacc Adopts Hybrid Business Model

Syneos Health Acquires Clinical Trial Recruitment and Retention Company StudyKIK

Related Breaking News

Biologics, Proteins, Vaccines | Breaking News | Industry News

New CDMO Vector BioMed Launches Operations

The biomanufacturing company’s mission is to provide access to high-quality lentiviral vectors and address the vector supply bottleneck.
02.01.23
Breaking News | Facilities | Industry News

Lilly to Invest $450M at Manufacturing Site in Research Triangle Park

Expansion includes additional parenteral filling, device assembly and packaging capacity to support an increased demand for Lilly's incretin products.
01.30.23
Vio Chemicals

...
Ioanna Kazantzidou, Marketing Communications Officer 11.18.22
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Lonza Further Invests in Drug Product Manufacturing Capabilities

New filling line to process various modalities, including monoclonal antibodies, bioconjugates, viral vectors, and other gene therapy products.
09.22.21
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials

Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany

Covers the combination of DHODH inhibitors and nucleoside analogues to treat viral infections, including Covid-19.
09.22.21